BioStem Technologies(BSEM)
$1.47+0.43 (+41.35%)
BSEM
BioStem Technologies financials statements
$1.47
At close:+0.43 (+41.35%)
Want to see BSEM full AI Analyst Report?
BioStem Technologies (BSEM) Ratios
316 Followers
BioStem Technologies Ratios
BSEM's free cash flow for Q2 2026 was $-5.59M. For the 2026 fiscal year, BSEM's free cash flow was decreased by $-56.13K and operating cash flow was $-5.54M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.12 | 1.35 | 0.81 | 0.23 | 0.14 |
| Quick Ratio | 3.85 | 1.33 | 0.76 | 0.17 | 0.10 |
| Cash Ratio | 2.74 | 0.23 | 0.02 | 0.12 | 0.05 |
| Solvency Ratio | -0.57 | 0.32 | -0.52 | -0.92 | -0.14 |
| Operating Cash Flow Ratio | 0.92 | 0.25 | -0.22 | -0.26 | -0.02 |
| Short-Term Operating Cash Flow Coverage | 3.08 | 6.02 | -0.79 | -0.40 | -0.04 |
| Net Current Asset Value | $ 33.51M | $ 34.09M | $ -3.31M | $ -5.93M | $ -7.53M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.03 | 0.33 | 1.50 | 1.81 |
| Debt-to-Equity Ratio | 0.09 | 0.11 | -3.55 | -1.28 | -0.81 |
| Debt-to-Capital Ratio | 0.08 | 0.10 | 1.39 | 4.60 | -4.28 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.25 | -0.34 | -0.43 |
| Financial Leverage Ratio | 1.28 | 3.44 | -10.83 | -0.85 | -0.45 |
| Debt Service Coverage Ratio | -2.01 | 7.04 | -1.47 | -1.45 | -0.17 |
| Interest Coverage Ratio | 0.00 | 53.13 | -11.11 | -10.00 | -3.05 |
| Debt to Market Cap | 0.05 | 0.02 | 0.06 | 0.15 | 0.39 |
| Interest Debt Per Share | 0.20 | 0.31 | 0.40 | 0.50 | 0.46 |
| Net Debt to EBITDA | 85.09 | -0.58 | -0.60 | -0.68 | -7.46 |
| Profitability Margins | |||||
| Gross Profit Margin | 93.13% | 95.37% | 92.44% | 87.17% | 66.03% |
| EBIT Margin | -1.45% | 10.34% | -46.64% | -98.38% | -20.41% |
| EBITDA Margin | -0.65% | 10.43% | -45.27% | -94.84% | -13.87% |
| Operating Profit Margin | -1.45% | 10.34% | -46.62% | -68.09% | -36.99% |
| Pretax Profit Margin | -0.82% | 10.14% | -50.84% | -103.47% | -32.52% |
| Net Profit Margin | -13.86% | 10.56% | -50.84% | -102.90% | -33.30% |
| Continuous Operations Profit Margin | -13.86% | 10.56% | -50.84% | -105.19% | -32.52% |
| Net Income Per EBT | 1688.95% | 104.15% | 100.00% | 99.45% | 102.38% |
| EBT Per EBIT | 56.54% | 98.12% | 109.05% | 151.95% | 87.92% |
| Return on Assets (ROA) | -13.15% | 22.69% | -58.26% | -204.10% | -54.10% |
| Return on Equity (ROE) | -16.81% | 78.00% | 631.00% | 173.56% | 24.25% |
| Return on Capital Employed (ROCE) | -1.76% | 75.40% | 733.45% | 163.59% | 41.50% |
| Return on Invested Capital (ROIC) | -1.62% | 68.50% | -226.80% | -371.76% | 190.54% |
| Return on Tangible Assets | -13.25% | 22.76% | -60.73% | -247.44% | -65.20% |
| Earnings Yield | -10.33% | 14.07% | -10.56% | -20.75% | -11.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.81 | 2.84 | 1.47 | 184.79 | 14.46 |
| Payables Turnover | 0.73 | 2.60 | 0.91 | 18.13 | 2.28 |
| Inventory Turnover | 1.13 | 7.54 | 1.92 | 2.23 | 5.67 |
| Fixed Asset Turnover | 9.03 | 153.51 | 12.19 | 5.01 | 3.40 |
| Asset Turnover | 0.95 | 2.15 | 1.15 | 1.98 | 1.62 |
| Working Capital Turnover Ratio | 1.39 | 19.12 | -4.24 | -1.32 | -0.75 |
| Cash Conversion Cycle | -99.10 | 36.44 | 36.71 | 145.44 | -70.60 |
| Days of Sales Outstanding | 75.91 | 128.46 | 248.76 | 1.98 | 25.24 |
| Days of Inventory Outstanding | 321.89 | 48.43 | 190.54 | 163.60 | 64.36 |
| Days of Payables Outstanding | 496.89 | 140.46 | 402.60 | 20.13 | 160.19 |
| Operating Cycle | 397.79 | 176.90 | 439.30 | 165.58 | 89.60 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.59 | 1.50 | -0.26 | -0.14 | -0.01 |
| Free Cash Flow Per Share | 0.39 | 1.47 | -0.26 | -0.18 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 2.97 | 57.38 | -33.22 | -3.49 | -2.55 |
| Capital Expenditure Coverage Ratio | 2.97 | 57.38 | -33.22 | -3.49 | -2.55 |
| Operating Cash Flow Coverage Ratio | 2.98 | 5.44 | -0.73 | -0.31 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.08 | -0.21 | -0.24 | -0.03 |
| Free Cash Flow Yield | 10.34% | 10.62% | -4.49% | -6.18% | -1.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -9.77 | 7.11 | -9.47 | -4.82 | -8.41 |
| Price-to-Sales (P/S) Ratio | 1.34 | 0.75 | 4.81 | 4.96 | 2.80 |
| Price-to-Book (P/B) Ratio | 1.63 | 5.54 | -59.75 | -8.37 | -2.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 9.67 | 9.42 | -22.29 | -16.19 | -79.80 |
| Price-to-Operating Cash Flow Ratio | 6.41 | 9.26 | -22.96 | -20.83 | -111.05 |
| Price-to-Earnings Growth (PEG) Ratio | 0.08 | -0.02 | 0.00 | -0.01 | 0.16 |
| Enterprise Value Multiple | -121.76 | 6.61 | -11.23 | -5.91 | -27.65 |
| Enterprise Value | 37.52M | 208.21M | 84.86M | 38.54M | 16.64M |
| EV to EBITDA | -121.76 | 6.61 | -11.23 | -5.91 | -27.65 |
| EV to Sales | 0.79 | 0.69 | 5.09 | 5.61 | 3.83 |
| EV to Free Cash Flow | 5.69 | 8.66 | -23.54 | -18.30 | -109.29 |
| EV to Operating Cash Flow | 3.77 | 8.51 | -24.25 | -23.54 | -152.08 |
| Tangible Book Value Per Share | 2.32 | 2.47 | -0.14 | -0.40 | -0.53 |
| Shareholders’ Equity Per Share | 2.34 | 2.50 | -0.10 | -0.36 | -0.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -15.89 | -0.04 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2.84 | 18.44 | 1.22 | 0.60 | 0.37 |
| Net Income Per Share | -0.39 | 1.95 | -0.62 | -0.62 | -0.12 |
| Tax Burden | 16.89 | 1.04 | 1.00 | 0.99 | 1.02 |
| Interest Burden | 0.57 | 0.98 | 1.09 | 1.05 | 1.59 |
| Research & Development to Revenue | 0.15 | 0.01 | 0.02 | 0.02 | 0.03 |
| SG&A to Revenue | 0.80 | 0.84 | 0.64 | 1.52 | 0.96 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.40 | 0.71 | 0.09 |
| Income Quality | -1.51 | 0.77 | 0.41 | 0.23 | 0.08 |
Currency in USD
